Showing 1841-1850 of 4730 results for "".
Systemic Inflammation in Psoriasis: A Guide for Dermatology Care Providers
https://practicaldermatology.com/topics/psoriasis/systemic-inflammation-in-psoriasis-a-guide-for-dermatology-care-providers/20439/Practical guidance for dermatology care providers on the importance of screening patients with psoriasis for associated comorbidities.The Role of GLP-1RAs in Treating Inflammatory Dermatologic Diseases
https://practicaldermatology.com/issues/novemberdecember-2025/the-role-of-glp-1ras-in-treating-inflammatory-dermatologic-diseases/48899/Herein, we review the benefits and risks of GLP-1RAs with a focus on these 3 chronic inflammatory conditions.Calcium Dependence of the SHH Pathway and Theoretical Implications in Oral Treatment of Locally Advanced or Metastatic Basal Cell Carcinomas
https://practicaldermatology.com/issues/supplements/calcium-dependence-of-the-shh-pathway-and-theoretical-implications-in-oral-treatment-of-locally-advanced-or-metastatic-basal-cell-carcinomas/21719/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-26/23564/Managing Pruritus in Geriatric Patients
https://practicaldermatology.com/topics/practice-management/managing-pruritus-in-geriatric-patients/21146/Treatment tips and considerations for this patient population.Thanks and Best Wishes
https://practicaldermatology.com/series/editors-message/thanks-and-best-wishes/23807/Politicizing Certification
https://practicaldermatology.com/topics/practice-management/politicizing-certification/21092/Drug Companies, Insurance Companies, Pharmacists, the Government, Doctors and…Oh, Patients!
https://practicaldermatology.com/topics/practice-management/drug-companies-insurance-companies-pharmacists-the-government-doctors-andoh-patients/21063/Pre-Treating Resectable Melanomas with PD-1 Inhibitors: An Emerging Strategy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pre-treating-resectable-melanomas-with-pd-1-inhibitors-an-emerging-strategy/20489/Pre-treatment with anti-PD1 agents may improve outcomes for some patients and provide prognostic clues.Histopathologic Assessment of Atypical Pigmented Lesions: Financial and Diagnostic Considerations
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histopathologic-assessment-of-atypical-pigmented-lesions-financial-and-diagnostic-considerations/21335/Taking prospective deeper sections may prove more cost-efficient in the long-term.